Vote Scores

Home / Companies / Biodesix, Inc. / 19 May 2026

Meeting · year to 30 June 202649 filers reporting

Biodesix, Inc.: meeting of 19 May 2026

Votes reported on Form N-PX, item by item

49 Form N-PX filers reported votes at the Biodesix, Inc. meeting of 19 May 2026. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

2 nominees; 70.6% of reported votes for; 5 filers withheld from or voted against at least one nominee.

30 vote records from 7 filers. 0 of the 7 filers that marked the item either way voted against management.

42.9% for0.0% against57.1% other0.0% against management7 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

63 vote records from 47 filers. 12 of the 41 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.

55.3% for29.8% against14.9% other29.3% against management47 filers67.4% for4.4% against28.1% other4.4% against management2,697,548 reported shares
3

SECTION 14A SAY-ON-PAY VOTESIssuer

Frequency of the say-on-pay vote

3: 1 filer; one year: 39 filers; not applicable: 2 filers; for: 1 filer.

64 vote records from 47 filers. 1 of the 40 filers that marked the item either way voted against management. 7 filers reported this item without a management mark.

2.1% for0.0% against97.9% other2.5% against management47 filers3.9% for0.0% against96.1% other27.5% against management2,758,221 reported shares
4

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

15 vote records from 7 filers. 0 of the 7 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management7 filers100.0% for0.0% against0.0% against management582,176 reported shares
5

Several categoriesSecurity holder

Shareholder proposals (not separable from the filings)

Filers described these proposals in wordings that could not be matched to one another, so they are shown together.

1 vote records from 1 filers. No filer marked a management recommendation, so no against-management figure is reported. 1 filer reported this item without a management mark.

100.0% for0.0% against1 filers

How the largest families voted

Family1. Directors2. Say-on-pay3. Pay-vote frequency4. Auditor
VanguardForForSplit or no voteFor
BlackRock and iSharesNo reportForSplit or no voteNo report
FidelityForForSplit or no voteFor
State Street and SPDRNo reportForSplit or no voteNo report
EquitableSplit or no voteAgainst *Split or no voteFor
Goldman SachsNo reportSplit or no voteSplit or no voteNo report
PGIM and PrudentialNo reportForSplit or no voteNo report
Northern Trust and FlexSharesNo reportAgainst *Split or no voteNo report
Guggenheim and RydexSplit or no voteAgainst *Split or no voteFor
BNY MellonNo reportAgainst *Split or no voteNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Biodesix, Inc. meeting?

49 Form N-PX filers reported votes at the meeting of 19 May 2026. On say-on-pay, 12 of 41 voted against management (29.3%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Biodesix, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Biodesix, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Biodesix, Inc. with a meeting date within three days of 19 May 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.